Tracon Pharmaceuticals | 10-Q: Quarterly report
Tracon Pharmaceuticals | 8-K: TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Tracon Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Lazar David E.
Tracon Pharmaceuticals | 8-K: Current report
Tracon Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Tracon Pharmaceuticals | 8-K: Current report
Tracon Pharmaceuticals | 424B5: Prospectus
Tracon Pharmaceuticals | 8-K: Current report
Tracon Pharmaceuticals | 8-K: Current report
Tracon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ikarian Capital, LLC(5.9%),Neil Shahrestani(5.9%)
Tracon Pharmaceuticals | 8-K: Current report
Tracon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-WAYNE AARONSON(2.3%)
Tracon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Brown Scott B.
Tracon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer THEUER CHARLES
Tracon Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Tracon Pharmaceuticals | 10-K: Annual report
Tracon Pharmaceuticals | 8-K: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Tracon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(0.375%),Lincoln Park Capital, LLC(0.375%), etc.
Tracon Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Opaleye Management Inc.(0.00%)
Tracon Pharmaceuticals | 8-K: Current report
No Data